Minerva
NERV

Minerva (NERV) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
JefferiesUpgradedHold → Buy$10.00 from $7.50Aug 14, 2026
CitizensInitiated CoverageMarket Outperform$14.00Apr 15, 2026
HC Wainwright & Co.MaintainedNeutral$7.00 from $4.00Mar 12, 2026
HC Wainwright & Co.MaintainedNeutral$4.00 from $5.00Nov 6, 2025
HC Wainwright & Co.MaintainedNeutral$5.00Feb 26, 2025
HC Wainwright & Co.MaintainedNeutral$5.00Nov 6, 2024
HC Wainwright & Co.MaintainedNeutral$5.00 from $7.00Aug 7, 2024
HC Wainwright & Co.MaintainedNeutral$7.00 from $11.00May 2, 2024
HC Wainwright & Co.MaintainedNeutral$11.00Feb 27, 2024
HC Wainwright & Co.MaintainedNeutral$11.00 from $8.00Aug 2, 2023
HC Wainwright & Co.MaintainedNeutral$8.00May 16, 2023
HC Wainwright & Co.MaintainedNeutral$8.00May 2, 2023
HC Wainwright & Co.MaintainedNeutral$8.00Mar 9, 2023

Frequently asked questions

  • What is the latest analyst rating on NERV?

    On Aug 14, 2026, Jefferies upgraded Minerva to Buy with a price target of $10.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.